News

The trial will enroll approximately 400 pediatric, geriatric and oncology patients at three sites who will be treated with either the novel guide wire-assisted peripheral IV catheter or

The results describe a new oral formulation of Irinotecan (IRN-SRN) encapsulated into nanoparticles allowing an oral release of the molecule. The company said that the aim of this

Under the agreement, Medicines for Malaria Venture (MMV) will have access to the Pfizer library of novel chemical entities, in order to screen it for compounds that have

With this acquisition, Schwabe will expand its presence in Austria and central & eastern Europe (CEE). Dirk Reischig, chairman and CEO of Dr Willmar Schwabe Pharmaceuticals, said: “We

Charles O’Neill, CEO of Avalon Healthcare, said: “A direct relationship with the Lee Memorial Health System (LMHS) provides an important first step in Avalon’s strategy to become an

As the newest member of Datatrak’s CRO Connect Program, Keypoint is able to expand its electronic data capture (EDC) capabilities and empower its staff to more efficiently manage

Dr. Smith is a distinguished clinician and research scientist, who has made major contributions to the Canadian cardiology and medical communities and, in recognition of his outstanding achievements,

Eli Lilly and Company has reported a net income of $1.31 billion, or $1.20 per share, for the first quarter of 2009, an increase of 23%, compared to

Sanofi Pasteur, the vaccines division of Sanofi-Aventis Group, has initiated clinical studies of its investigational tetravalent dengue vaccine in Singapore and Vietnam. With these studies, Sanofi Pasteur is